Tvardi Therapeutics, Inc. beat EPS estimates 0% of the time across 3 reported quarters (0 beats, 3 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.65 | $-0.69 | -6.2% | Miss |
| Q12026 FY2026 | $-0.65 | $-0.73 | -12.3% | Miss |
| Q42025 FY2025 | $-0.55 | $-0.78 | -41.8% | Miss |
Back to TVRD overview · TVRD holders · TVRD KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.